However the field develops, Trapp says the control of weight through GLP-1 is a genuine game-changer
Importantly, weight loss with GLP-1 RAs has accompanied improvements in metabolic parameters and obesity-related comorbidities (e.g., glycemic control, lipid profiles, liver enzymes) in adolescents, mirroring findings in adults (see e.g., NASPGHAN and Endocrine guidelines)
But this process can be gradual, taking place over a period of weeks to months as you slowly increase your dosage of the medication
Patients who have repeated weight measurements might be the extremes of weight change.
Anecdotal reports suggest that the burps, like other gastrointestinal issues, are worse when patients begin taking their drugs or step up to higher dosages